Table 2.
TNF-α, IL-6 and IL-1β in Terminal Ileum, Cecum and Rectum of IBS patients, IBD Patients and Controls
Bowel parts, cytokines | IBD |
IBS |
Controls |
|||
---|---|---|---|---|---|---|
Epithelium intensity | Crypts intensity | Epithelium intensity | Crypts intensity | Epithelium intensity | Crypts intensity | |
Terminal ileum | ||||||
TNF-α | 1.00a | 0.68 | 2.38b | 2.00 | 1.94b | 1.61 |
IL-6 | 2.17a | 1.89a | 1.65b | 1.22b | 1.95b | 1.70b |
IL-1β | 2.31a | 2.31a | 2.70a,b | 2.95a,b | 2.84b | 2.85b |
Cecum | ||||||
TNF-α | 0.80a | 0.80 | 2.90b | 2.35 | 2.38c | 2.00 |
IL-6 | 2.31a | 2.16a | 1.72b | 1.41b | 1.76b | 1.40b |
IL-1β | 2.65a | 2.56a | 3.05b | 3.10b | 3.25b | 2.65b |
Rectum | ||||||
TNF-α | 1.17a | 1.17 | 2.55b | 2.30 | 2.63b | 2.15b |
IL-6 | 1.87a | 2.08a | 1.73b | 1.46b | 1.55b | 1.47b |
IL-1β | 2.54a | 2.46a | 2.91b | 2.95b | 3.10b | 2.89b |
Statistically significant;
P<0.05.,
P<0.01, and
P<0.001.
IL, interleukin.